Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline May 31, 2017 FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017 Novo Nordisk A/S – Share Repurchase Programme June 25, 2017
FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017
